Email
Password
Remember meForgot password?
    Log in with Twitter

Pharmaceutical News

Foreign patients turn to India in search of cut-price cures

New Delhi - When doctors told Australian Greg Jefferys he had Hepatitis C and the disease was destroying his liver, the devastating diagnosis was compounded by the cost of a cure.

'Major shortcomings' in French drug trial death lab: Inquiry

Paris - An inquiry into the death of a man during a drug trial has found "three major shortcomings" at the French laboratory where he was being tested, the minister of health said.

Researchers scramble to fight 'brand new' Zika virus

Miami - Zika virus is spreading rapidly through the Americas leaving researchers scrambling to understand the very basics, including how to prevent, treat and diagnose the emerging mosquito-borne threat.

Johnson and Johnson cut 3,000 jobs

One of the biggest healthcare companies in the U.S. has announced a high number of job cuts in its medical device business.

No reason to stop drug trials despite death: French minister

Paris - There is no reason to stop clinical trials in France, the country's health minister said Monday, despite the death of a man during testing for a new drug.

Man dies after being left brain-dead in French drug trial

Rennes - A man who was left brain-dead after suffering serious side-effects during a drugs trial in France died on Sunday, according to the hospital which had been treating him.

Reviled US pharma chief arrested on fraud charges

New York - A reviled US pharmaceutical boss who caused a storm in September by jacking up the price of a life-saving drug by 5,000 percent has been arrested on fraud charges, prosecutors said.

Bayer sued in Germany over contraceptive pill after health scares

Willst - "If I'd known, I'd never have taken this pill," says Felicitas Rohrer, who is suing German pharmaceuticals giant Bayer, claiming its oral contraceptive Yasminelle caused her to suffer a pulmonary embolism.

New class of leukaemia drug approved

London - The U.K. body responsible for approving medications for the health service has recently approved a new type of leukaemia drug. The drug works in a different way from those in current use.

Germany seizes record haul of illegal sex and diet pills

Berlin - German customs investigators said Thursday they had seized their largest-ever haul of illegal pharmaceuticals -- 3.5 million pills from India, mostly slimming and sexual potency "lifestyle drugs".

Pharma companies lobby U.K. government over spending cuts

London - A number of life science sector bodies, both private and public sector, have lobbied the U.K. government in relation to proposed cuts to research and development into new medicinal products.

Doctors warn of snakebite serum shortage

Paris - Tens of thousands of people will unnecessarily die of snakebites unless an affordable new source of antivenom is found, Doctors Without Borders has warned, with stocks of a French-produced drug running out.

Breakthrough in quest for Ebola vaccine

Paris - An Ebola test vaccine provided blanket protection in a field trial in Guinea, researchers said, possibly heralding "the beginning of the end" for the devastating West African outbreak that has killed thousands.

Promise seen for drug in patients with early Alzheimer's

Washington - A new kind of drug to fight Alzheimer's has shown promise when given to people in the early stages of the disease, drug-maker Eli Lilly said Wednesday.

23andMe to begin drug development

Mountain View - 23andMe, the personal genomics firm, has announced plans to make its own medicines. This will involve deals with biotechnology and pharmaceutical companies.

Swiss drugmaker Roche buys another U.S. company

Swiss pharmaceutical company Roche has bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.

New hepatitis drugs raise political pressure in Spain

Madrid - The arrival in Europe of better but pricier hepatitis C drugs has raised pressure on Spanish leaders over health spending cuts which sufferers say deprive them of life-saving treatments.

Biotech companies partner for Parkinson’s research

The biotech companies 23andMe and Genentech are to work together on research into Parkinson’s Disease. The firms have entered a multi-year deal for the analysis of whole-genome sequence data.

Researchers discover key antibiotic power of honey bee bacteria

Lund - A budding discovery courtesy of research teams at Lund University in Sweeden may open the door to defeating deadly, antibiotic-resistant bacteria.

China jails British, US investigators hired by GSK

Beijing - A British investigator once hired by scandal-hit pharmaceutical giant GSK in China was sentenced to two-and-a-half years in jail for breaching privacy laws, a court said Friday.

Lawsuit claims stem cells unsafe

San Fransisco - StemCells, Inc., a California company developing cell therapies for a range of conditions, is being sued by a former employee who claims that the company did not follow proper protocol in preparing treatments.

China indicts GSK-linked foreign investigators: Xinhua

Shanghai - Prosecutors in Shanghai have indicted two foreign investigators linked to drugmaker GlaxoSmithKline (GSK), which is at the centre of a bribery scandal in China, state media reported Monday.

Chinese herb beats drug at rheumatoid arthritis: study

Paris - A Chinese herb called thunder god vine works better than a widely-prescribed pharmaceutical drug at easing rheumatoid arthritis, a study published on Monday said.

Investors bet Sun Pharma can restore Ranbaxy to health

New Delhi - On the surface, Sun Pharma's $3.2-billion purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal.

WHO urges global push to treat hepatitis C

Geneva - The World Health Organization called Wednesday for a dramatic increase in screening and treatment of hepatitis C, saying higher demand would help drive down the cost of drugs for the disease.

Drugmakers ordered to pay $9 billion for hiding cancer risks

Japan's biggest pharmaceutical company has been hit with a $6 billion penalty for concealing cancer risks associated with its Actos diabetes drug while Eli Lilly and Co, Takeda's co-defendant in the case, was ordered to pay $3 billion in punitive damages.

US recommends aspirin for some pregnant women

Washington - A small subset of pregnant women could benefit from taking low-dose aspirin to prevent the potentially life-threatening complication called pre-eclampsia, US health authorities said Tuesday.

Promise seen with Pfizer breast cancer drug

Washington - An experimental cancer drug made by Pfizer has shown signs of promise at slowing the spread of advanced breast cancer, researchers said.

Indian drug maker Sun to buy troubled peer Ranbaxy for $4.0 bln

New Delhi - Top Indian drug giant Sun Pharmaceutical Industries said Monday it had agreed to buy its troubled peer Ranbaxy for $4.0 billion in stock, ending its ill-fated six-year control by Japan's Daiichi Sankyo.

Novartis replaces top Japan executives over drug trial scandal

Tokyo - Swiss pharmaceutical giant Novartis said on Thursday it was replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.
  1 2 3 Next»

Set up a news alert for

Pharmaceutical


Pharmaceutical Image

Sanofi Pasteur headquarters  Lyon
Sanofi Pasteur headquarters, Lyon
Sanofi Pasteur / Diana Romero
Bayer sign
Bayer sign
Metropolico.org
AstraZeneca  Canadian office  Mississauga  Ontario
AstraZeneca, Canadian office, Mississauga, Ontario
AstraZeneca Canada Inc.
Bayer factory in Leverkusen  Germany
Bayer factory in Leverkusen, Germany
A. Savin

Latest News
Top News